C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations
- Submitting institution
-
King's College London
- Unit of assessment
- 2 - Public Health, Health Services and Primary Care
- Output identifier
- 113759653
- Type
- D - Journal article
- DOI
-
10.1056/NEJMoa1803185
- Title of journal
- New England Journal of Medicine
- Article number
- -
- First page
- 111
- Volume
- 381
- Issue
- 2
- ISSN
- 1533-4406
- Open access status
- Compliant
- Month of publication
- July
- Year of publication
- 2019
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
16
- Research group(s)
-
-
- Citation count
- 54
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- A. The researcher was the COPD expert in the trial and was closely involved in its design from the beginning. He chose the COPD-specific outcome measures, led the interpretation of those measures, and advised on their analysis.
B. The researcher contributed to the drafting of the paper from the beginning, particularly with respect to the COPD elements.
- Non-English
- No
- English abstract
- -
